Its earnings before interest, taxes, depreciation, and amortization (EBITDA) is seen rising 15% to RON94 million.
MedLife expects the group results to be impacted in the future by factors such as improved macroeconomic conditions and people’s general health condition, which boost the demand for private medical services.
On an individual level, MedLife expects to switch to profit, envisaging a net result of RON9.6 million in 2018, compared to a loss of RON2.5 million a year before.